Skip to content

Evaluation of a New Blood Pressure Measuring Device.

A Study to Evaluate the Safety and Effectiveness (Overall Performance) of the Press-O-Sense Non-Invasive Blood Pressure Measuring Device.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00265707
Enrollment
120
Registered
2005-12-15
Start date
2005-09-30
Completion date
2005-12-31
Last updated
2006-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Hypotension

Brief summary

* A disposable blood pressure measuring device will be tested and compared to a standard mercury sphygmomanometer. * Up to 100 subjects with various levels of blood pressure values will be tested.

Detailed description

The study will comprise 85 to 100 subjects with blood pressure values ranging between 90 and 170mmHg -systolic and 65-95 -diastolic. * Three sets of measurements will be performed on each subject. The measurement with the tested device placed between twh determinations with a mercury sphygmomanometer. * Each measurement will be performed simultaneously by two examiners specially trained. * Informed consent will be obtained from all participants. * The results will be evaluated by a standard statistical plan ANSI/AAMI SP-10 2002.

Interventions

DEVICEBlood pressure measurement

Sponsors

Maaynei Hayesha Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, age 18 years or above * Signed written informed consent

Exclusion criteria

* A history of cardiac arrythmia * Wrist circumference smaller than 13cm or larger than 19.5cm * Documented peripheral vascular disease * Damage or injury to the left wrist * Participation in any other clinical study * Any acute coronary of cardiovascular illness

Design outcomes

Primary

MeasureTime frame
The difference between the paired measurements with the tested device and the reference measurements (with a mercury sphygmomanometer) will differ by no more than +-5mmHg.

Countries

Israel

Contacts

Primary ContactMordchai Ravid, MD FACP
ravid@mhmc.co.il972-3-5771113
Backup ContactItzhak Klinger, MD
klinger@mhmc.co.il972-3-5771216

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026